Adalimumab (Q1092019): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Updating entity Adalimumab with Lapacz) |
(Changed an Item: Updating statements of entity ["Adalimumab" (pl)] with Lapacz) |
||
Property / Version | |||
Property / Version: Yaromir / rank | |||
Property / National Library Identifier | |||
a0000003407221 | |||
Property / National Library Identifier: a0000003407221 / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Leki immunosupresyjne / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Przeciwciała monoklonalne / rank | |||
Normal rank | |||
Property / Related Subject | |||
Property / Related Subject: Choroba Leśniowskiego-Crohna / rank | |||
Normal rank | |||
Property / Type | |||
Property / Type: Unknown / rank | |||
Normal rank | |||
Property / Version | |||
P52170T47192 | |||
Property / Version: P52170T47192 / rank | |||
Normal rank |
Latest revision as of 22:54, 7 December 2023
No description defined
Language | Label | Description | Also known as |
---|---|---|---|
English | Adalimumab |
No description defined |
Statements
a0000003407221
0 references
P52170T47192
0 references